Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  China Medical System Holdings Limited    0867   KYG211081248

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

(0867)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M CNY Estimates in M CNY
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 4 901 5 349 5 433 5 977 6 601 6 827
EBITDA 1 692 2 071 2 200 2 516 2 731 2 768
Operating profit (EBIT) 1 516 1 874 2 001 2 324 2 509 2 545
Pre-Tax Profit (EBT) 1 500 1 808 2 006 2 387 2 501 2 612
Net income 1 376 1 675 1 850 2 186 2 293 2 391
P/E ratio 19,9x 22,5x 8,59x 10,5x 9,83x 9,56x
EPS ( CNY ) 0,55 0,67 0,74 0,88 0,94 0,97
Dividend per Share ( CNY ) 0,22 0,27 0,30 0,34 0,38 0,36
Yield 2,02% 1,77% 4,65% 3,69% 4,14% 3,93%
Reference price ( CNY ) 10,997 15,173 6,392 9,240 9,240 9,240
Announcement Date 03/23/2017
10:04pm
03/19/2018
02:16pm
03/18/2019
01:33pm
- - -
Finances - Leverage
Actuals in M CNY Estimates in M CNY
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 1 130 1 249 650 - - -
Finance - - - 425 2 048 1 481
Operating income (EBITDA) 1 692 2 071 2 200 2 516 2 731 2 768
Leverage
(Debt/EBITDA)
0,67x 0,60x 0,30x - - -
Capital Expenditure 1 074 1 103 33,9 207 212 333
Free Cash Flow (FCF) 1 019 969 1 721 2 165 2 145 2 248
Book Value Per Share (BVPS) ( CNY ) 2,50 2,92 3,37 3,96 4,55 5,15
Cash Flow per Share ( CNY ) 0,43 0,83 0,71 0,87 1,39 1,02
Announcement Date 03/23/2017
10:04pm
03/19/2018
02:16pm
03/18/2019
01:33pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 22 919 M CNY -
Entreprise Value (EV) 22 494 M CNY 20 871 M CNY
Valuation 2019e 2020e
P/E ratio (Price / EPS) 10,5x 9,83x
Capitalization / Revenue 3,83x 3,47x
EV / Revenue 3,76x 3,41x
EV / EBITDA 8,94x 8,24x
Yield (DPS / Price) 3,69% 4,14%
Price to book (Price / BVPS) 2,33x 2,03x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 38,9% 38,0%
Operating Leverage (Delta EBIT / Delta Sales) 1,61x 0,76x
Net Margin (Net Profit / Revenue) 36,6% 34,7%
ROA (Net Profit / Asset) 19,3% 17,6%
ROE (Net Profit / Equities) 24,1% 20,9%
Rate of Dividend 38,7% 40,8%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,46% 3,21%
Cash Flow / Sales 36,1% 52,1%
Capital Intensity (Assets / Sales) 1,89x 1,97x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend